Asthma Research
Asthma is a common chronic inflammatory disease of the respiratory system that affects approximately 22 million people in US. It has been classified as a complex genetic condition that is determined by the interaction of numerous genes along with environmental factors.
Asthma Research Products Targets
- Adenosine A2B Receptor (7)
- Adenosine A2A Receptor (11)
- Matrix Metalloprotease (16)
- Caspase (9)
- Elastase (1)
- Lipoxygenase (8)
- Leukotriene and Related Receptor (13)
- Bradykinin Receptor (12)
- Cytokine Receptor (4)
- Urokinase (2)
- Deubiquitinating Enzyme (12)
- Aminopeptidase (5)
- Angiotensin-Converting Enzyme (8)
- Carboxypeptidase (1)
- Calpain (7)
- Histamine H4 Receptor (12)
- Histamine H3 Receptor (22)
- Histamine H2 Receptor (10)
- Histamine H1 Receptor (17)
- Adenosine A3 Receptor (8)
- Adenosine A1 Receptor (12)
- IαB Kinase (6)
- Calcium-Activated Potassium (KCa) Channel (19)
- Dipeptidyl Peptidase IV (1)
- Cathepsin (9)
- gamma-Secretase (9)
- ADAMs (1)
- Proteasome (5)
Products for Asthma Research
- Cat.No. Product Name Information/Activity
-
BCC5904
Bombinakinin M
509151-65-9
-
BCC5996
Sar-[D-Phe8]-des-Arg9-Bradykinin
126959-88-4
![Sar-[D-Phe8]-des-Arg9-Bradykinin chemical structure](/media/images/struct/BCC5996.png)
-
BCC5995
[Phe8Ψ(CH-NH)-Arg9]-Bradykinin
118122-39-7
![[Phe8Ψ(CH-NH)-Arg9]-Bradykinin chemical structure](/media/images/struct/BCC5995.png)
-
BCC5993
Lys-Bradykinin
342-10-9
-
BCC5991
Lys-[Des-Arg9]Bradykinin
71800-36-7
![Lys-[Des-Arg9]Bradykinin chemical structure](/media/images/struct/BCC5991.png)
-
BCC5964
HOE 140
Icatibant (HOE-140) is a selective and specific antagonist of bradykinin B2 receptor with IC50 and Ki of 1.07 nM and 0.798 nM respectively.
-
BCC6094
MEN 11270
235082-52-7
-
BCC3819
Noscapine HCl
Bradykinin antagonist. Also tubulin inhibitor
-
BCC6014
R 715
185052-09-9
-
BCC5992
R 892
229030-05-1
